Azucena Esparís‐Ogando
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 7
- Oncology top 5%
- HER2/EGFR in Cancer Research 13
- Molecular Biology top 5%
- Melanoma and MAPK Pathways 16
- Protein Kinase Regulation and GTPase Signaling 11
- Glycosylation and Glycoproteins Research 6
- Cancer Research top 10%
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Cancer Mechanisms and Therapy 5
-
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Atanasio PandiellaJuan Carlos MonteroElena Díaz‐RodríguezLaura YusteAlberto OcañaRuth Rodríguez‐BarruecoPiero CrespoMar Abad
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Azucena Esparís‐Ogando
45 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 84
- Immunology and Allergy 229
- Oncology 861
- Molecular Biology 1.3k
- Cancer Research 262
- Radiology, Nuclear Medicine and Imaging 310
Countries citing papers authored by Azucena Esparís‐Ogando
This map shows the geographic impact of Azucena Esparís‐Ogando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azucena Esparís‐Ogando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azucena Esparís‐Ogando more than expected).
Fields of papers citing papers by Azucena Esparís‐Ogando
This network shows the impact of papers produced by Azucena Esparís‐Ogando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azucena Esparís‐Ogando. The network helps show where Azucena Esparís‐Ogando may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Azucena Esparís‐Ogando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 1 | |
| 5 | 2021 | 29 | |
| 6 | 2020 | 18 | |
| 7 | 2019 | 41 | |
| 8 | 2019 | 24 | |
| 9 | 2019 | 77 | |
| 10 | 2014 | 54 | |
| 11 | 2013 | 43 | |
| 12 | 2012 | 76 | |
| 13 | 2009 | 78 | |
| 14 | 2009 | 40 | |
| 15 | 2005 | 3 | |
| 16 | 2005 | 52 | |
| 17 | 2004 | 44 | |
| 18 | 1999 | 46 | |
| 19 | 1989 | 15 | |
| 20 | 1988 | 8 |
About Azucena Esparís‐Ogando
Azucena Esparís‐Ogando is a scholar working on Immunology and Allergy, Oncology and Molecular Biology, having authored 45 papers that have together received 2.0k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (16 papers), HER2/EGFR in Cancer Research (13 papers), Protein Kinase Regulation and GTPase Signaling (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Cell Adhesion Molecules Research (7 papers), Glycosylation and Glycoproteins Research (6 papers), Cancer Mechanisms and Therapy (5 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Immunology and Allergy (229 citations), Oncology (861 citations) and Molecular Biology (1.3k citations). Azucena Esparís‐Ogando has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Atanasio Pandiella, Juan Carlos Montero, Elena Díaz‐Rodríguez, Laura Yuste, Alberto Ocaña, Ruth Rodríguez‐Barrueco, Piero Crespo, Mar Abad, Jesús F. San Miguel and Joaquı́n Teixidó. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.